Left Atrial Appendage Exclusion (LAAE) is recommended during heart surgery by The Society of Thoracic Surgeons, American College of Cardiology, and the American Heart Association
Reduced antiarrhythmic drug use, superior freedom from Atrial Arrhythmia recurrence* and fewer repeat ablations are just a few of the positive outcomes we’re seeing two years out with the randomized-controlled CEASE-AF Trial using Hybrid ablation and LAAE compared to endocardial… https://t.co/4r7mTE23xo
Cryo Nerve Block provides non-opioid pain relief, numbing the surgical site for up to 3 months.
cryoNB is a crucial addition to pain-management care as options can become limited post-op.
Learn more about #cryoNB: https://t.co/fEMOTe7qZT#PatientsFirst#CardioTwitter
At #AATS2024, we engaged with physicians from around the globe, delving into the forefront of Afib treatment and post-op pain management. Of particular significance was Dr. McCarthy's presentation on the impactful effects of LAAE in non-AF cardiac patients. Witnessing such… https://t.co/SJk6IYuqVq
AtriCure is dedicated to addressing the underserved market of those affected by Afib and post-op pain. With Q1 wrapped, we’re proud to report a strong first quarter.
Read the full earnings report at: https://t.co/VJbkwJxE9T#FinancialResults#Earnings
On this Nurses Day, we pause to honor the remarkable dedication of over 3 million nurses in the United States and millions more across the globe.
Their commitment to serving others often leads them down unexpected but rewarding career paths. Through their compassionate care, nurses like Jessica elevate patient experiences everywhere.
Join us in celebrating nurses for their tireless contributions to better healthcare outcomes. #NursesDay#NursesWeek
As we observe Military Appreciation Month, we extend our deepest gratitude to all those who have served and continue to serve our country with unwavering courage and dedication.
Your sacrifice and commitment to protecting our freedoms are truly inspiring. Today and every day, we salute our military heroes and their families for their selflessness and bravery. Thank you for your service!
#MilitaryAppreciationMonth
We’re proud to support Greater Cincinnati’s American Heart Association's 20th Go Red for Women Anniversary and their mission for championing better health and well-being for all women. With a focus on connection and engagement, this year’s event was a powerful reminder of our shared mission for help others.
Diversity fuels innovation, fosters creativity, and drives us towards excellence. Today, we're thrilled to share a powerful message from our employee Joanna, highlighting the importance and value diversity brings to the workplace.
Join us in honoring and celebrating Asian American and Pacific Islander Heritage Month.
#AAPIHeritageMonth#DiversityMatters
Reduced antiarrhythmic drug use, superior freedom from Atrial Arrhythmia recurrence* and fewer repeat ablations are just a few of the positive outcomes we’re seeing two years out with the randomized-controlled CEASE-AF Trial using Hybrid ablation and LAAE compared to endocardial ablation alone.
To learn more about the CEASE-AF Trial, visit https://okt.to/mbQeau
*Freedom from atrial arrhythmias were defined as atrial fibrillation, atrial flutter, atrial tachycardia in patients off anti-arrhythmic drugs (AADs) except previously failed AADs at doses not exceeding those previously failed. Patients had an enlarged left atrium >4 cm ≤ 6 cm.
Hybrid data were directly compared to endocardial ablation alone.
As a non-opioid pain-management option, Cryo Nerve Block disrupts pain signals, allowing the surgical site to become temporarily numb for up to three months while the nerves slowly regenerate.
With post-op pain management options becoming limited once leaving the hospital, Cryo Nerve Block is offering both surgical teams and patients a new option for post-op care.
Learn more at: https://okt.to/pTjGeI#cryoNB#PatientsFirst
What an enriching experience at #AATS2024! Over four days, we engaged with physicians from around the globe, delving into the forefront of Afib treatment and post-op pain management. Of particular significance was Dr. Patrick McCarthy's highly anticipated presentation on the impactful effects of LAA Exclusion in non-Afib cardiac patients. Witnessing such groundbreaking progress in our field is truly inspiring.
AtriCure is dedicated to addressing the underserved market of those affected by Afib and post-op pain. With Q1 wrapped, we’re proud to report a strong first quarter.
Read the full earnings report at: https://okt.to/hgHpIu#FinancialResults#Earnings
social media channels to keep updated on the latest at AtriCure.
Blake's Pectus Excavatum Journey: 2 Months Post-Op
Duration: 2:31
Blake's Pectus Excavatum Journey: Surgery
Duration: 2:49
Blake's Pectus Excavatum Journey: 1 Week Pre-Op
Duration: 3:41
Blake's Pectus Excavatum Journey: 1 Month Pre-Op
Duration: 2:58